Clinical Trials Browser

Withdrawn × Observational × Standard of Care × Clear all

NCT04926168 2022-08-10

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Glioblastoma

NCT02261051 2016-04-22

LCCM-Control

Death, Neoplasms, Patient Acceptance of Health Care